Transgenic models of human immunodeficiency virus type-1

Area of Science:

• * Virology
• * Immunology
• * Molecular Biology

Background:

• * Transgenic models have been instrumental in elucidating the complex mechanisms of human immunodeficiency virus type 1 (HIV-1) pathogenesis.
• * These models have shed light on specific conditions such as Kaposi's sarcoma and HIV-associated nephropathy.
• * Research has explored the tissue-restricted expression of central nervous system (CNS) strains of HIV-1 and the in vivo function of the Nef protein.

Purpose of the Study:

• * To review the contributions of transgenic models to understanding HIV-1 pathogenesis.
• * To highlight the utility of both multigenic and single gene constructs in studying HIV-1-induced diseases.
• * To assess the potential of these models for developing and testing molecular therapies for acquired immunodeficiency syndrome (AIDS).

Main Methods:

• * Utilization of genetically engineered animal models carrying HIV-1 genes or fragments.
• * Analysis of disease manifestations and viral protein functions in vivo.
• * Comparison of insights gained from single gene versus multigenic constructs.

Main Results:

• * Transgenic models have significantly advanced the understanding of HIV-1 pathogenesis, including Kaposi's sarcoma and nephropathy.
• * These models have elucidated the role of specific viral components like Nef and the expression patterns of CNS strains.
• * While not ideal for vaccine development, they offer crucial insights into disease mechanisms.

Conclusions:

• * Transgenic models are powerful tools for dissecting HIV-1 pathogenesis and associated pathologies.
• * They provide a platform for studying the in vivo function of viral proteins and gene expression.
• * These models hold promise for the future development and evaluation of molecular-based therapies for AIDS.